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ABSTRACT
The mammary gland undergoes significant remodeling dur-
ing pregnancy and lactation, which is fuelled by controlled
mammary stem cell (MaSC) proliferation. The scarcity of
human lactating breast tissue specimens and the low num-
bers and quiescent state of MaSCs in the resting breast have
hindered understanding of both normal MaSC dynamics
and the molecular determinants that drive their aberrant
self-renewal in breast cancer. Here, we demonstrate that
human breastmilk contains stem cells (hBSCs) with multili-
neage properties. Breastmilk cells from different donors dis-
played variable expression of pluripotency genes normally
found in human embryonic stem cells (hESCs). These genes
included the transcription factors (TFs) OCT4, SOX2,
NANOG, known to constitute the core self-renewal circuitry
of hESCs. When cultured in the presence of mouse embry-
onic feeder fibroblasts, a population of hBSCs exhibited an
encapsulated ESC-like colony morphology and phenotype
and could be passaged in secondary and tertiary clonogenic
cultures. While self-renewal TFs were found silenced in the
normal resting epithelium, they were dramatically upregu-
lated in breastmilk cells cultured in 3D spheroid conditions.
Furthermore, hBSCs differentiated in vitro into cell line-
ages from all three germ layers. These findings provide
evidence that breastmilk represents a novel and noninvasive
source of patient-specific stem cells with multilineage poten-
tial and establish a method for expansion of these cells in
culture. They also highlight the potential of these cells to be
used as novel models to understand adult stem cell plasticity
and breast cancer, with potential use in bioengineering and
tissue regeneration. STEM CELLS 2012;30:2164–2174
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INTRODUCTION
Embryonic stem cells (ESCs) derive from the inner mass of
mammalian blastocysts and have the ability to self-renew and
differentiate into all body cell types [1]. Self-renewing stem
cells also exist in adult tissues buffered within specialized
niches. They escape their quiescent state in response to devel-
opmental and physical cues in order to maintain homeostasis
during tissue turnover or injury [2]. Initially it was thought
that adult stem cells have limited differentiation potential re-
stricted to the tissue/organ of origin. However, recent evi-
dence has suggested that certain cell subpopulations within
adult stem cell compartments are capable of in vitro and in
vivo differentiation into cell types outside their dermal origin
under specific microenvironments [3–7].
In the mammary gland, bipotent stem cells (MaSCs) capa-
ble of differentiation toward the two main mammary epithe-
lial lineages (myoepithelial and luminal) as well as a hierar-
chy of progenitor cells are known to exist in the epithelium
[8–15]. The existence of stem cells in this organ was first
postulated based on the capacity of the mammary epithelium
to significantly expand and regress in a repeated fashion
throughout adult life [16]. In accordance with this, MaSCs
exist in a quiescent state and in scarce numbers in the resting
breast, but are activated during pregnancy and lactation,
undergoing a controlled program of proliferation, differentia-
tion, and apoptosis stimulated by hormonally-driven cues
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[17–19]. In addition to their physiological role during preg-
nancy and lactation, increasing evidence implicates MaSCs in
the onset and progression of invasive breast carcinomas with
metastatic features and propensity toward both mesodermal
(bone) and endodermal (lung) organs [20, 21]. These findings
suggest that the mammary gland harbors a stem cell popula-
tion with unique self-renewal capabilities and a potential plas-
ticity reflected both in normal development and in aberrant
conditions of the breast. To date, the molecular determinants
and regulators of MaSC normal and aberrant self-renewal and
plasticity are unknown due to limited understanding of normal
MaSC biology and the absence of cell culture model systems
to propagate and characterize these cells. Progress has been
hindered by the scarcity and quiescent state of MaSCs in the
resting breast and the extremely limited availability of human
lactating breast tissues, which contain activated MaSCs in
greater numbers [15, 22].
Previously, we demonstrated that the activated MaSC pool
of the human lactating breast can be accessed noninvasively
via expressed breastmilk [23–26]. Stem cells and differenti-
ated cells from the lactating epithelium enter breastmilk either
through cell migration and turnover and/or as a consequence
of the mechanical shear forces of breastfeeding. Culture of
CD49fþ human breastmilk-derived stem cells (hBSCs) in 2D
conditions and 3D biomatrices revealed their ability to differ-
entiate toward myoepithelial (CK14þ) and luminal (CK18þ)
mammary cells, demonstrating properties of MaSCs [24–26].
In this study, we sought to examine regulators of the self-
renewal of hBSCs and their plasticity and potential to differ-
entiate toward cell types outside the mammary lineage. A
novel stem cell population was identified in breastmilk,
expressing an array of ESC-associated genes, including the
transcription factors (TFs) OCT4, SOX2, NANOG, and
KLF4. In situ histological examination of rare human lactat-
ing breast tissue specimens revealed the origin and localiza-
tion of this hBSC population in the lactating breast epithe-
lium, being almost absent in normal resting breast tissue
biopsies. Upon coculture with mouse embryonic feeder fibro-
blasts (MEFs) in ESC growth conditions, hBSCs exhibited an
encapsulated ESC-like colony morphology and phenotype.
Moreover, under differentiation conditions hBSCs differenti-
ated into cell types from all three germ layers. These findings
demonstrate that the normal lactating breast contains a cell
population expressing self-renewal ESC TFs. This, together
with the previously reported upregulation of these TFs in
breast and ovarian malignancies [27–32], implicates them
both in the normal and aberrant expansion of these organs.
The presence of these cells in breastmilk highlights it as a
novel and noninvasive source of multipotent patient-specific
stem cells, with the potential for application in regenerative
medicine and in studies of molecular determinants of cancer.
MATERIALS AND METHODS
Breastmilk Sample Collection
The study was approved by the Human Research Ethics Commit-
tee of The University of Western Australia and the institutional
review board (IRB) of the University of North Carolina at Chapel
Hill, and all participants provided informed written consent.
Healthy breastfeeding women (>70) were recruited in Australia
and USA, covering a wide range of lactation stages, from month
1 to year 5, through one or multiple children. Pump-expressed
mature breastmilk (5–200 ml) was obtained from each participant
and was transported to the laboratory immediately upon expres-
sion under aseptic conditions.
Breastmilk Cell Isolation
Breastmilk was diluted with equal volume of sterile phosphate
buffered saline (PBS) (pH 7.4, Gibco, Grand Island, NY, http://
www.invitrogen.com) and centrifuged at 805g for 20 minutes at
20C. The fat layer and liquid part skim milk were removed, and
the cell pellet was washed three times in PBS and resuspended in
7% fetal bovine serum (FBS, Certified, Invitrogen, Carlsbad, CA,
http://www.invitrogen. com) in PBS (blocking buffer). The total
cell concentration and viability of each sample were determined
with a Neubauer hemocytometer by Trypan Blue exclusion.
Cell Culture
The human embryonic stem cell line H7 (WiCell via the Human Em-
bryonic Core at UNC, Madison, WI, http://www.wicell.org) was
maintained at 37C and 5% CO2 in hESC medium containing Dul-
becco’s modified Eagle’s medium (DMEM)/F12 (Gibco), 20%
knockout serum replacement (Invitrogen), 5 ng/ml human basic
fibroblast growth factor (Sigma-Aldrich, St. Louis, MO, http://
www.sigmaaldrich.com), 100 lM nonessential amino acids (NEAA,
Invitrogen), 100 lM b-mercaptoethanol (Sigma-Aldrich), 5% antibi-
otic/antimycotic (Invitrogen), and 2 lL/ml fungizone (Invitrogen).
Mammary epithelial cells isolated from resting breast mammoplas-
ties were maintained in human mammary epithelial cell (HuMEC)
complete medium (Invitrogen). These cells were derived from nor-
mal resting breast tissue procured from the Tissue Procurement Core
Facility of the University of North Carolina Lineberger Comprehen-
sive Cancer Center in accordance with approved IRB protocols (Bio-
medical IRB, study 09-0777). Primary neonatal human fibroblasts
were cultured in DMEM (Gibco) supplemented with 10% FBS (Invi-
trogen) and 1% antibiotic/antimycotic. Breastmilk cells were seeded
in gelatin-coated plates on MEFs in MEF-conditioned hESC medium
at densities ranging from 5  105 to 5  106 per 35 mm dish and
incubated at 37C and 5% CO2, with daily media changes after day
5. For secondary and tertiary feeder culture, single colonies were
individually picked and transferred to new plates in appropriate vol-
ume of fresh medium in a split ratio of 1:2. For spheroid culture,
breastmilk cells were seeded in ultra-low binding plates (Co-Star,
Corning, Tewksbury, USA, http://www.corning.com) in Mammo-
Cult medium (Stem Cell Technologies, Vancouver, BC, Canada,
http://www.stemcell.com) supplemented with 3% antibiotic/antimy-
cotic and 2 lL/ml fungizone. For passaging of adherent colonies or
spheroids in feeder-free conditions, the cells were trypsinized
(Gibco) for 5 minutes at 37C and split 1:3.
Flow Cytometry
Antibodies against ESC markers were standardized using human
fibroblasts as negative control (Fig. 1) and were shown to recog-
nize their target proteins by fluorescence-activated cell sorting
(FACS) (Stemgent, USA, https://www.stemgent.com/; Santa Cruz
Biotechnology, Santa Cruz, CA, http://www.scbt.com). Freshly
isolated breastmilk cells were incubated in primary antibody
(Supporting Information Table S1) for 30 minutes at 4C, fol-
lowed by washes and secondary antibody incubation (AlexaFluor
488 or 647 nm, Invitrogen) for 30 minutes at 4C at 1:300, and
finally washed and resuspended in fixative (1% paraformaralde-
hyde/0.7% sucrose in PBS). For surface markers, all incubations
and washes were done in blocking buffer, while for intracellular
markers in 0.05% Tween-20 in PBS after initial cell fixation.
Cells were also incubated with live/dead fixable cell stain (Invi-
trogen) according to the manufacturer’s instructions and only the
live cells were considered for data analyses. Appropriate negative
internal controls were used. Data acquisition was done with a
FACS Calibur Flow Cytometer (Becton Dickinson, Franklin
Lakes, NJ, http://www.bd.com) and data analysis with FlowJo.
Quantitative Real-Time Polymerase Chain Reaction
Total RNA from freshly isolated breastmilk cells, harvested
hBSC-derived spheroids, hESC H7 cell line, mammary epithelial
cells derived from resting tissue mammoplasties, and human
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primary neonatal fibroblasts was extracted with an RNeasy extrac-
tion kit (Qiagen, Valencia, CA, http://www1.qiagen.com) follow-
ing the instructions of the manufacturer. Total RNA was reverse-
transcribed using the high-capacity cDNA archive kit (Applied
Biosystems, Carlsbad, CA, http://www.appliedbiosystems.com)
plus RNase inhibitor (Applied Biosystems). Gene transcription
was quantified by quantitative real-time polymerase chain reaction
(qRT-PCR) using hydrolytic probes (Taqman, Applied Biosys-
tems; Supporting Information Table S2) with the 7500 Fast
RT-PCR system (Applied Biosystems). Each sample was
measured in triplicates or in few cases in duplicates when the
extracted RNA was not adequate. Fold change in gene expression
for each sample and experimental condition was calculated as
2Ct(control)  Ct(sample) 6 SD.
Western Blotting
Breastmilk cells, human fibroblasts (negative control), and OTBCs
(OCT4-transduced breast cells) [33] (positive control) were lysed
in RIPA buffer for 30 minutes on ice. Protein was quantified using
the Micro BCA protein kit (Thermo Scientific, USA, http://
www.thermoscientific.com). Protein denaturation was done for 5
minutes at 95C. 50 lg of protein was loaded into Biorad TGX
stain-free gels, which were run at 300 V for 30 minutes. Protein
was transferred onto membranes using a Trans-Blot Turbo System
(Biorad). Membranes were washed in 0.05% TBS-T, stained with
Ponceau red for 5 minutes, destained with dH2O, and washed in
0.05% TBS-T. Membranes were blocked using 5% nonfat cow’s
skim milk for 1 hour, incubated with primary antibodies (Support-
ing Information Table S1) overnight at 4C, washed in 0.05%
TBS-T, and incubated with secondary antibodies with 1:10,000
Streptoactin for 1 hour at room temperature. Subsequently, mem-
branes were washed in 0.05% TBS-T before incubation in Chemi-
luminescence Crescendo (Millipore) for 5 minutes. Imaging was
done using a Chemi-Doc MP (Biorad).
Culture supernatants from breastmilk cells cultured under
mammary differentiation conditions were harvested on weeks 2–4
of culture and examined for the presence of a-lactalbumin and
lactoferrin. Fresh medium and human breastmilk/purified proteins
were used as negative and positive controls, respectively. 200 lg
of total protein from the culture supernatants was loaded per well
of a 10% polyacrylamide gel and run under SDS/PAGE denatur-
ing conditions. Proteins were transferred to a nitrocellulose mem-
brane and blocked for 1 hour in 5% cow’s skim milk. Antibodies
were applied at the concentrations listed in Supporting Informa-
tion Table S1. Membranes were then developed (ECL-Plus, GE
Healthcare, Piscataway, NJ) and visualized by autoradiography.
In Vitro Differentiation
To examine the ability of hBSCs to spontaneously differentiate,
breastmilk cells were initially grown as spheroids (see above). By
Figure 1. Human breastmilk cells from the lactating mammary epithelium express embryonic stem cell (ESC) genes. (A): Immunostaining of nor-
mal human resting and lactating breast tissues for expression of ESC genes (OCT4, SOX2, NANOG, SSEA4, and TRA-1-60/81). The absence or
minimal expression of ESC genes in the resting breast epithelium is contrasted by the presence of positively stained cells in the alveolar and ductal
epithelium of the lactating breast. Positive cells were also observed in the alveolar/ductal lumen, suggesting their presence in breastmilk. Nuclei
were stained with 40,6-diamidino-2-phenylindole (DAPI) (blue). Scale bars ¼ 10 lm. (B): Ex vivo immunostaining of freshly isolated breastmilk
cells for expression of ESC genes. The first three micrographs show negative control cells (human fibroblasts; scale bars ¼ 50 lm). Nuclei were
stained with Hoechst 33342 (blue). Scale bars ¼ 2.5 lm. (C): Fluorescence-activated cell sorting (FACS) analysis of freshly isolated breastmilk cells
for expression of ESC genes. The first panel shows negative control cells (human fibroblasts). For each marker, examples of FACS breastmilk cell
expression profiles from three participants are shown. (D): Western blotting showing expression of OCT4, SOX2, and NANOG by freshly isolated
breastmilk cells. b-Actin was used as a housekeeping gene. -Fibrob.: human fibroblasts (negative control); OTBCs: OTBC-L1 (positive control); S1–
S4 breastmilk samples. Abbreviations: APC, allophycocyanin; OTBC, OCT4-transduced breast cells; FITC, fluorescein isothiocyanate.
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day 4–7, some cells had attached. The remaining spheroids were
transferred into new wells where adherent cells appeared in 1–2
days. Both the initial and subsequent attached cells were cultured
for another 2–3 weeks, with media changes every 3–5 days. For
directed differentiation, primary and first- to third-passage breast-
milk cell cultures were incubated in differentiation media at 37C
and 5% CO2 for 3–4 weeks. For mammary differentiation, cells
were incubated in Roswell Park Memorial Institute medium
(RPMI) 1640 with L-glutamine (Invitrogen) supplemented with
20% FBS, 4 lg/ml insulin (Invitrogen), 20 ng/ml epidermal
growth factor (EGF) (Invitrogen), 0.5 lg/ml hydrocortisone
(Sigma-Aldrich), 5% antibiotic-antimycotic, and 2 lL/ml fungi-
zone. For osteoblastic and adipogenic differentiation, cells were
incubated in NH OsteoDiff or NH Adipodiff medium, respec-
tively (Miltenyi Biotec, Bergisch Gladbach, Germany, http://
www.miltenyibiotec.com). For chondrocyte differentiation, cells
were incubated for 3–4 weeks in StemPro Chondrogenesis Differ-
entiation medium (Life Technologies, Rockville, MD, http://
www.lifetech.com). For neuronal differentiation, cells were incu-
bated in RPMI 1640 with L-glutamine, supplemented with 20%
FBS, 4 lg/ml insulin, 20 ng/ml EGF, 0.5 lg/ml hydrocortisone,
5% antibiotic-antimycotic, 2 lL/ml fungizone, 20 ng/ml prolactin
(Peprotech, Rocky Hill, NJ, http://www.peprotech.com), and
MACS Supplement B27 (Miltenyi Biotec). For hepatocyte differ-
entiation, cells were cultured in Williams’ E basic medium sup-
plemented with 10% FBS, 2.5 lg/ml fungizone, 5% antibiotic/
antimycotic, 2 mM glutamine (Sigma-Aldrich), 6.25 lg/ml ITS
(insulin, human transferrin, and selenious acid supplement) (Invi-
trogen), 20 ng/ml EGF (BD Biosciences), 10 mM nicotinamide,
and 107 M dexamethasone. For pancreatic differentiation, cells
were first incubated for 2 days in high-glucose DMEM supple-
mented with 10% FBS, 2.5 lg/ml fungizone, 5% antibiotic/anti-
mycotic, 2 mM glutamine, 6.25 lg/ml ITS, 20 ng/ml EGF, 50
ng/ml activin A (Sigma-Aldrich), and 106 mol/L retinoic acid
(Sigma-Aldrich). For the next 9–12 days, cells were incubated in
DMEM/F12 supplemented with 10% FBS, 2.5 lg/ml fungizone,
5% antibiotic/antimycotic, 2 mM glutamine, 6.25 lg/ml ITS, 20
ng/ml EGF, 10 mM nicotinamide, 107 M dexamethasone, and
300 nmol/L indolactam V (Sigma-Aldrich). For the final 2–4
days of differentiation, the above medium was supplemented with
50 ng/ml activin A. For cardiomyocyte differentiation, cells were
cultured in DMEM/F12 supplemented with 20% FBS, 5% horse
serum (Invitrogen), 2 mM L-glutamine, 0.1 M NEAA, 3 mM so-
dium pyruvate (Invitrogen), 1 lg/ml insulin, 2.5 lg/ml fungizone,
and 5% antibiotic/antimycotic.
Mammary Tissues for Immunohistochemistry
Lactating and resting mammary tissue sections (5 lm-thick,
derived from three different tissue blocks for each type) were pre-
pared from normal human biopsied formalin-fixed and paraffin-
embedded tissue currently available in the tissue archive of the
School of Anatomy, Physiology and Human Biology, The Uni-
versity of Western Australia.
Immunostaining
Antibodies for ESC markers were standardized using human
fibroblasts as negative control cells (Fig. 1). All antibodies used
were shown to recognize their target proteins by immunocyto-
chemistry (Supporting Information Table S1). Part of the breast-
milk cell suspensions was immediately fixed in 1.5% paraformar-
aldehyde/0.7% sucrose in PBS and cytospins were generated
using a Shandon Cytospin 3 centrifuge at 40.7g for 4 minutes.
Primary antibodies (Supporting Information Table S1) were
applied in blocking buffer for 1 hour at room temperature in a
humid chamber, after a 5-minute permeabilization with 0.05%
Tween-20 in PBS for intracellular markers. Cytospins were
washed, incubated with secondary antibody (AlexaFluor 488,
546, or 555 nm, Invitrogen) in blocking buffer at 1:300 and
DAPI (1:100, Roche) for 30 minutes, washed and mounted in
DakoCytomation Fluor. mounting medium. Adherent cells grown
on plastic plates were fixed as above, permeabilized in 0.1%
Triton X-100 in PBS for 30 minutes, incubated with primary and
secondary antibodies as above, washed and resuspended in fixa-
tive. Spheroids were fixed in 3% formaraldehyde in PBS, perme-
abilized in 0.1% PBS-Triton X-100 for 20 minutes, washed and
stained with primary and secondary antibodies (as above) for 6
hours and 2 hours, respectively. Breast tissue sections were rehy-
drated in deionized water overnight at 4C, followed by a 10-mi-
nute incubation in PBS, permeabilization in 0.1% PBS-Triton-X
100 for 15 minutes in a humid chamber, and a wash in PBS prior
to overnight incubation at room temperature with primary antibody
(Supporting Information Table S1) in blocking buffer. The sections
were then washed in PBS and incubated with secondary antibody
(as above) for 2 hours, followed by a final wash and mounting.
Appropriate negative controls (with no primary antibody incuba-
tion) were used to standardize imaging, which was done using a
Nikon A1Si Confocal microscope, an Olympus TH4-200 inverted
optical microscope, a Nikon Eclipse Ti inverted optical microscope
or a Leica DMIRB Inverted Fluorescence/DIC microscope.
Teratoma Formation Assay
The protocol was approved by the Animal Research Ethics Com-
mittees of The University of Western Australia and the University
of North Carolina at Chapel Hill. Freshly isolated breastmilk cells
(3  106–32  106) or spheroid-derived breastmilk cells (2 
105–107) were suspended in 30% Matrigel (BD Biosciences) in
PBS and injected subcutaneously into dorsal flanks of 15 severe
combined immunodeficient (SCID) mice. Nine weeks after injec-
tion, mice were examined for tumor formation. p86-OTBC-L1
(OCT4-tranduced breast cells) [33] were used as positive control.
Statistical Analysis
All statistical analyses, including descriptive statistics, graphical
exploration of the data, and Student’s t-tests for statistical signifi-
cance were performed in Microsoft Excel and in R 2.9.0 one
[34]. The results are presented as mean 6 SEM as indicated in
figure legends, and p values are shown in the figures.
RESULTS
Human Breastmilk Contains a Population of Cells
Expressing ESC Genes
We set out to examine molecular determinants of self-renewal
and indicators of plasticity in MaSCs in human breast tissue
specimens by immunofluorescence microscopy (IF). Normal
human resting and lactating breast biopsies were examined
for expression of genes that constitute the core circuitry of
self-renewal in hESCs. No or minimal expression of OCT4,
SOX2, NANOG, SSEA4, and TRA-1-60/TRA-1-81 was
observed in resting mammary tissues (Fig. 1A). By contrast,
ESC-associated genes were clearly expressed in normal lactat-
ing mammary tissues, where distinct patterns of gene expres-
sion were recorded (Fig. 1A). The TFs OCT4, SOX2, and
NANOG were expressed both in the luminal and basal epithe-
lial layers in the alveoli and ducts of the lactating epithelium
(Fig. 1A). Differences were observed in the distribution and
level of ESC gene expression between different ducts and al-
veolar batches, confirming a previously reported developmen-
tal heterogeneicity between different epithelial compartments
within the same breast tissue [35]. Moreover, even within a
duct or alveolus expression differences were evident among
different epithelial cells, ranging from absence of expression,
minimal cytoplasmic expression, clear nuclear expression, and
mixed cytoplasmic and nuclear expression within a cell (Fig.
1B). For all three TFs, the highest expression level was
observed in the myoepithelial layer compared to the luminal
layer both in ducts and alveoli. SSEA4 was more irregularly
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expressed in both ducts and alveoli (Fig. 1A). TRA-1-60 and
TRA-1-81 were restricted to the luminal cell surface in
alveoli but were more irregularly expressed in ducts. Coex-
pression of these markers was observed in cell subpopulations
in the ductal and alveolar zones. Cells positive for these
markers were also captured in the lumen of ducts and alveoli
(Fig. 1A), suggesting their presence in breastmilk.
To noninvasively access this enriched ESC-geneþ cell
pool from the lactating breast, we used freshly expressed
breastmilk. Total breastmilk cells were isolated and examined
for ex vivo expression of ESC-associated genes at the mRNA
and protein levels, using IF (Fig. 1B), FACS (Fig. 1C), West-
ern blotting (WB) (Fig. 1D), and qRT-PCR (Fig. 2A). All
antibodies and probes were first standardized using human
fibroblasts as negative control (Fig. 1B, 1C). A clear nuclear,
and sometimes perinuclear or cytoplasmic localization of
OCT4, SOX2, and NANOG was observed using IF in breast-
milk cell subpopulations, whereas SSEA4 and TRA-1-60/
TRA-1-81 were localized on the cell surface (Fig. 1B). An
analytic gating strategy was developed for quantification of
protein expression by FACS, which included exclusion of in-
terference by dead cells and/or fat globules (Supporting Infor-
mation Fig. S1a). A remarkable variation in expression levels
was observed by FACS among the breastmilk cell prepara-
tions examined, ranging 4%–96% of total cells for OCT4,
SOX2, and NANOG, and 0.1%–93% for the surface antigens
SSEA4 and TRA-1-60/TRA-1-81 (Supporting Information Ta-
ble S3; Fig. S1b). Among these genes, TRA-1-60/TRA-1-81
and NANOG were the most highly expressed, followed by
OCT4 (Supporting Information Fig. S1b). Coexpression of
these genes by single cells was demonstrated both with IF
and FACS (Supporting Information Fig. S2). Similar to the
variation at the protein level, which was confirmed also by
WB (Fig. 1D), a wide variation was observed in mRNA
expression levels among samples from different women
(Fig. 2A). OCT4, SOX2, and NANOG mRNA expression was
Figure 2. Breastmilk stem cells expressing ESC genes display clonogeneicity and ESC-like colony morphology and phenotype. (A): Quantita-
tive real-time polymerase chain reaction (PCR) assay for expression of OCT4, SOX2, NANOG, and KLF4 by human breastmilk cells in 17
breastmilk samples (S1–S17), and comparison with human fibroblasts, mammary epithelial cells isolated from resting breast mammoplasties, and
hESCs. Individual PCR reactions were normalized against internal controls (GAPDH) and plotted relative to the expression level of the fibro-
blasts. Bars represent the mean 6 SEM. (B): Coculture of human breastmilk-derived stem cells (hBSCs) with mouse embryonic feeder fibroblasts
in hESC medium resulted in formation of two distinct types of adherent colonies: ESC-like breastmilk-derived colonies (second panel) with mor-
phology similar to hESCs (cell line H7, first panel); and non-ESC-like breastmilk-derived colonies (third panel) with various morphologies. All
ESC-like hBSC colonies expressed OCT4, SOX2, NANOG, SSEA4, SSEA3, and TRA-1-60, similar to hESC line H7. Most non-ESC-like colo-
nies expressed these genes at low levels, if at all. Scale bars ¼ 50 lm. Abbreviation: hESCs, human embryonic stem cells.
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lower in hBSCs compared to the hESC line H7 but signifi-
cantly higher than that of human fibroblasts and cells derived
from resting breast mammoplasties (p < 0.0001) (Fig. 2A).
Among the breastmilk samples analyzed, the highest level of
ESC gene mRNA expression was observed in a participant
who was breastfeeding and was concurrently pregnant to her
next child. hBSCs expressed NANOG mRNA at higher levels
compared to OCT4 and SOX2, which was consistent with the
results obtained using IF and FACS for protein expression.
Interestingly, KLF4 expression by hBSCs was significantly
higher than that of hESCs (p < 0.0001) (Fig. 2A). In addition
to the above ESC-associated genes, hBSCs expressed REX1,
hTERT, and GDF3 at variable levels, with some samples
showing comparable or slightly higher expression than that of
hESCs (Supporting Information Fig. S3). These results
established expression of ESC-associated genes at the protein
and mRNA levels by a subpopulation of breastmilk cells.
Clonogeneicity of Breastmilk Stem Cells Expressing
ESC Genes
A distinguishing property of hESCs is the formation of flat,
compact, and encapsulated colonies in coculture with MEFs in
hESC medium [36]. These colonies typically express the pluri-
potency genes OCT4, SOX2, NANOG, SSEA4, and TRA-1-60/
TRA-1-81 (Fig. 2B). To examine the clonogeneicity, morphol-
ogy, and phenotype of hBSCs in coculture with MEFs and com-
pare it with that of hESCs, cells isolated from freshly expressed
breastmilk were cultured with MEFs in hESC medium. A rapid
cellular proliferation was observed first in suspension, during
which individual cells divided and formed spherical structures.
Although expansion in suspension continued, within 4–7 days
of plating adherent individual cells and colonies appeared. The
suspension cells were removed with the first media change, and
the adherent colonies were allowed to expand. Two distinct
types of adherent colonies were observed: ESC-like flat, com-
pact, encapsulated colonies with high nucleus:cytoplasm ratio,
and non-ESC-like colonies (Fig. 2B). The non-ESC-like colo-
nies had various morphologies, from a mesenchymal-like to an
epithelial-like or mixed morphology (Fig. 2B). The formation
frequency of the two colony types differed between different
breastmilk samples, with 68%–100% (mean 90% 6 3%, n ¼
11) of all colonies displaying the ESC-like morphology. In our
hands and for the breastmilk samples tested, the frequency of
ESC-like colony forming cells ranged 1 in 15,000 to 1 in
1,750,000 (n¼ 11) (Supporting Information Table S4).
All ESC-like hBSC colonies expressed OCT4, SOX2,
NANOG, SSEA4, SSEA3, and TRA-1-60/TRA-1-81, with the
TFs being localized primarily in the nucleus (Fig. 2B). Simi-
larly to hESCs, spontaneous differentiation in the center of
the ESC-like colonies was occasionally observed, particularly
when they were allowed to expand for more than 2 weeks.
Most non-ESC-like colonies expressed these genes at low lev-
els, if at all. Based on TF gene expression, three distinct cell
types were observed within the non-ESC-like colonies: nega-
tive cells, dimly positive cells with TF expression primarily
in the cytoplasm, and few smaller round weakly attached cells
that were clearly positive in the nucleus (Fig. 2B). SSEA4
and TRA-1-60/TRA-1-81 were expressed at higher levels than
the TFs in the non-ESC-like colonies, but at lower levels than
in the ESC-like colonies. It must be noted that in addition to
colonies, single attached cells that failed to expand in 2D
were also observed. Many of these cells expressed ESC-asso-
ciated markers at high levels. The nature and properties of
these cells remain to be established.
ESC-like colonies were passaged in secondary and tertiary
feeder cultures, where they generated identical colonies with
ESC-like morphology and phenotype. Similar colony forma-
tion characteristics were observed when breastmilk cells were
cultured in the absence of feeders in gelatin-coated or
uncoated adhesion plates (Supporting Information Fig. S4a),
although attachment and colony formation success was higher
in the presence of feeders. By contrast, ESC-associated TFs
were not expressed in cultures derived from mammoplastic
reductions of resting breast tissue (Fig. 2A; Supporting Infor-
mation Fig. S4b). These data suggest that a subpopulation of
hBSCs possesses ESC-like features and clonogeneicity.
3D Culture of Breastmilk Stem Cells Enriches
for Self-Renewal ESC TFs
As we observed a propensity for initial expansion of hBSCs
in suspension via spheroid formation (even in adhesion
plates), we next examined characteristics of breastmilk cells
when cultured in 3D in ultra-low binding plates. These condi-
tions are well known to enrich for the presence of stem and
progenitor cells in a cell population [12]. With or without the
presence of extracellular matrix (Matrigel), breastmilk cells
rapidly formed spheroids, which could be successfully main-
tained through several passages (Fig. 3A; Supporting Informa-
tion Fig. S4c). Typically, the most rapid increase in spheroid
size was observed within the first 1–4 days (Fig. 3A). The
ability of spheroid formation, spheroid sizes, and size increase
in the course of culture varied between different breastmilk
samples, with smaller magnitude variations observed also
between spheroids of the same sample. Expression of ESC-
associated genes by breastmilk-derived spheroids was con-
firmed by IF (Fig. 3A), which also revealed coexpression of
these genes (Supporting Information Fig. S4d), and by qRT-
PCR (Fig. 3B).
Interestingly, a significant upregulation of self-renewal
TFs was observed during spheroid formation that equalled or
sometimes exceeded the mRNA expression levels of hESCs.
A time-course analysis of OCT4, SOX2, and NANOG mRNA
expression from day 1 to day 12 of spheroid formation
revealed a stable upregulation of these genes, which typically
peaked after day 7, and reached or exceeded the expression
levels of hESCs (Fig. 3B). Of note, variations in the extent of
upregulation of ESC-associated genes and the day on which
expression levels peaked were observed among different
breastmilk samples (Supporting Information Fig. S5). There-
fore, culture of breastmilk cells in suspension provides a rapid
method for expansion of a hBSC population that expresses
self-renewal genes associated with ESCs.
Differentiation of Breastmilk Stem Cells into Cells
Originating from the Three Germ Layers
To determine the differentiation potential of hBSCs, we followed
three approaches. In hESCs and human induced pluripotent cells
(hiPSCs), an initial embryoid body formation in 3D and subse-
quent cultivation of the embryoid bodies in adherent conditions
results in mixed spontaneous differentiation into cells from all
three germ layers [36, 37]. Breastmilk cells cultured in adherence
plates first formed spheroids and by day 4–7 some cells had
attached. After 2–3 weeks, the resultant cultures contained a mix-
ture of adherent cells/colonies with various morphologies, includ-
ing those of epithelial cells, mesenchymal cells, neural cells, and
cobblestone-like cells, which stained positive for corresponding
markers (Supporting Information Fig. S6).
In a second approach, we examined lineage-directed dif-
ferentiation of breastmilk cells when cultured in 2D in spe-
cific growth media, using methods previously reported for
hESCs and hiPSCs [36]. Initially, the potential of differentia-
tion into the two mammary lineages was confirmed. Within
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the first 2 weeks of culture in mammary differentiation condi-
tions, myoepithelial cells (CK14þ, SMAþ) were observed in
the attached colonies (Fig. 4A). On week 3, luminal cells
(CK18þ/CD49f) were detected, some of which spontane-
ously synthesized milk proteins (b-casein, lactoferrin, a-lactal-
bumin), which were secreted and detected in the culture su-
pernatant (Fig. 4B; Supporting Information Fig. S7). Under
neurogenic culture conditions, cells with neuronal morphology
and expression of nestin and b-III-tubulin were detected
within 2–3 weeks of culture (Fig. 4A). Under osteoblastic
conditions, we detected cells with nuclear expression of
RUNX2, a TF essential for osteoblastic differentiation (Fig.
4A). Some RUNX2þ cells coexpressed OSX, an osteoblast-
specific TF required for bone formation (Fig. 4A). Under
chondrogenic conditions, cells with the chondrocyte marker
profile (RUNX2þ/SOX6þ) were identified after 2–3 weeks of
culture (Fig. 4A). Under conditions promoting adipogenic dif-
ferentiation, cells positive for the adipogenic TF PPAR-c,
which developed large lipid droplets (oil red Oþ) were
observed (Fig. 4A). Breastmilk cells cultured in hepatocyte
differentiation conditions initially upregulated the endodermal
progenitor marker OV6, which was subsequently downregu-
lated with concurrent upregulation of the mature hepatocyte
markers a-fetoprotein and M2 isoenzyme of pyruvate kinase
(M2PK), and the functional hepatocyte marker albumin (Fig.
4A). Under pancreatic differentiation conditions, upregulation
of the mature beta cell marker PDX1 was observed, and
expression of insulin in the resulting cells was confirmed by
IF and qRT-PCR (Fig. 4A, 4C).
In a third approach, directed differentiation in 3D condi-
tions was examined by growing breastmilk-derived spheroids
in differentiation media for a longer period. Indeed, in corre-
sponding media, mammospheres producing milk proteins
(b-casein), pancreatospheres expressing insulin, and cardio-
spheres expressing cardiac T troponin were obtained within 3–
4 weeks of culture (Supporting Information Fig. S8). In all dif-
ferentiation inductions, upregulation of the differentiation genes
was accompanied by downregulation of ESC-associated genes.
Teratoma Assay of Breastmilk Cells
To establish whether breastmilk cells are capable of forming
teratomas when injected subcutaneously into dorsal flanks of
immunodeficient (SCID) mice, 15 mice were injected with
freshly isolated total breastmilk cells (3  106–32  106) or
with spheroid-derived breastmilk cells (2  105–107). Nine
weeks after injection, mice were examined and no tumor for-
mation was observed. By contrast, positive control animals
injected with as few as 50 p86-OTBC-L1 (OCT4-tranduced
breast cancer cells) showed formation of poorly differentiated
tumors [33].
DISCUSSION
We have shown that a stem cell population with multilineage
potential that expresses self-renewal TFs typical of ESCs
exists in the human lactating breast and can be noninvasively
accessed via breastmilk. This cell population was almost
absent from the normal resting breast, suggesting (a) that at
least some of these cells may be mobilized from other tissues,
and/or (b) that it is remnant from embryonic development in
the resting breast, where it is extremely scarce and in a quies-
cent state. We speculate that pregnancy/lactation-associated
hormonal cues activate this cell population via stimulation of
a self-renewal program mediated by a marked upregulation of
ESC-associated genes.
The lactating mammary epithelium was characterized by a
cellular hierarchy reflected in the cellular heterogeneicity
observed in breastmilk. Typically, a high, yet variable, per-
centage of cells expressing the ESC pluripotency TF circuitry
was found. Nevertheless, the differing subcellular localization
Figure 3. Breastmilk stem cells expressing embryonic stem cell (ESC) genes display self-renewal in 3D culture. (A): 3D culture of breastmilk
cells and formation of single cell-originated spheroids that expressed ESC genes (OCT4, SOX2, NANOG, SSEA4, and TRA-1-60) and which
could be serially passaged, demonstrating self-renewal. Typically, the most rapid increase in spheroid size was observed within the first 1–4 days
(first two panels). Nuclei were stained with 40,6-diamidino-2-phenylindole (DAPI) (blue). Scale bars ¼ 20 lm. (B): Time-course of ESC gene
expression by breastmilk cells in 3D culture conditions, demonstrating upregulation of ESC genes during the first 12 days of spheroid formation.
Quantitative real-time polymerase chain reaction (PCR) assay for expression of OCT4, SOX2, and NANOG in four breastmilk-derived cell sam-
ples (S1–S4) from four different participants at day zero (D0 – fresh breastmilk cells prior to culture), and then days 1–12 (D1–D12) of spheroid
growth. Each point on the graphs represents the mean 6 SEM. Individual PCR reactions were normalized against internal controls (GAPDH) and
plotted relative to the expression level of human fibroblasts. For comparison purposes, expression levels of the hESC line H7 are shown in bars
(mean 6 SEM). More examples are shown in Supporting Information Figure S5.
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(from cytoplasmic to perinuclear to nuclear) and levels of
expression among different cells further reinforce the presence
of a cellular hierarchy, from earlier-stage stem cells to com-
mitted progenitors, and potential stages in between. Although
all these cells express ESC-associated genes at some level, we
propose that not all are at the same developmental stage and
not all have the same self-renewal and differentiation poten-
tial. This was reflected at the much lower frequency of ESC-
like colony formation by breastmilk-derived cells in feeder
culture. Importantly, these colonies could be serially passaged
in secondary and tertiary feeder cultures, demonstrating clono-
geneicity. In addition to ESC-like colonies, non-ESC-like col-
onies were observed, some of which retained low expression
of ESC-associated genes. The non-ESC-like colonies dis-
played varying morphologies, from epithelial to mesenchymal
to mixed. Based on these findings, we hypothesize that the
non-ESC-like colonies originate from the expansion of more
committed progenitors present in breastmilk, suggesting that
ESC-associated genes are not completely downregulated in
the more committed mammary progenitor cells.
It therefore becomes clear that a wide spectrum of devel-
opmental stages and functionalities is represented in breast-
milk. Among the more committed progenitor and differenti-
ated cells, breastmilk contains a stem cell population, which
shares some properties with hESCs, yet it is not identical to
them. Freshly isolated breastmilk cells expressed the core TF
network governing pluripotency in hESCs [38]. Interestingly,
of the three TFs, NANOG was expressed at higher levels
among the breastmilk samples tested. NANOG is the key
self-renewal regulator essential for early development and for
maintaining the ground-state pluripotency of ESCs [39]. With
the exception of KLF4, which was expressed at much higher
levels by breastmilk cells compared to hESCs, expression lev-
els of the other ESC genes examined were variable and gener-
ally lower than hESCs. This could reflect the heterogeneicity
of the breastmilk cellular compartment or the lower expres-
sion of the markers by hBSCs, or both, and reinforces the
concept of a unique cellular composition of breastmilk. Inter-
estingly, 3D culture conditions enriched for the ESC-gene-
expressing hBSCs in a time-dependent manner, with expres-
sion levels of ESC-associated genes that equalled or exceeded
those of hESCs. This is in accordance with previous studies
reporting increased expression of OCT4 during spheroid cul-
ture of breast cancer cell lines [40] and of epithelial cells
derived from resting breast tissue mammoplasties (Blancafort,
unpublished data). However, the increase in OCT4 expression
Figure 4. Breastmilk stem cells differentiate into cells of the three germ layers. (A): Immunostaining for mammoectodermal, neuroectodermal,
endodermal, and mesodermal differentiation under corresponding growth conditions. Mammary differentiation: Myoepithelial cells (CK14þ,
SMAþ) and luminal cells (CK18þ/CD49f), some of which synthesized milk proteins (b-casein). Neural differentiation: Neuronal-like colonies
expressing b-III-tubulin. Hepatocyte differentiation: Initial upregulation of the endodermal progenitor marker OV6 and subsequent upregulation
of the mature hepatocyte markers AFP and M2PK, and the functional hepatocyte marker albumin. Pancreatic differentiation: Pancreatic beta cells
(PDX1þ/insulinþ). Osteogenic differentiation: Colonies with the osteoblastic profile (RUNX2þ/OSXþ). Chondrogenic differentiation: Colonies
with the chondrocyte marker profile (RUNX2þ/SOX6þ). Adipogenic differentiation: PPAR-cþ cells that formed large lipid droplets (oil red Oþ).
Nuclei were stained with 40,6-diamidino-2-phenylindole (DAPI) (blue). Scale bars ¼ 20 lm. (B): Western Blot analysis of secreted milk proteins
(a-lactalbumin and lactoferrin) in culture supernatants under mammary differentiation conditions. Breastmilk and purified proteins were used as
positive controls, and fresh medium as negative control. (C): Quantitative real-time polymerase chain reaction (PCR) assay for insulin expression
in breastmilk-derived cultures under pancreatic differentiation conditions. Insulin mRNA expression levels in freshly isolated breastmilk cells
(BM-fresh) and breastmilk cells cultured under pancreatic conditions (BM-panc) are compared with those of mammary epithelial cells isolated
from resting breast mammoplasties (RB) and human fibroblasts (FB) cultured under the same pancreatic differentiation conditions. Individual
PCR reactions were normalized against internal controls (GAPDH) and plotted relative to the expression level of RB. Bars represent the mean 6
SEM. Abbreviation: AFP, a-fetoprotein.
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during spheroid culture in both breast cancer cell lines and
normal epithelial cells from resting breast tissue is in the
order of three to five times, whereas in hBSCs in the order of
hundreds to thousands of times, often reaching or exceeding
the expression levels of hESCs (Fig. 3B). These findings sup-
port the pre-existence in the resting breast of a quiescent stem
cell population, which expands during pregnancy and lactation
and provide a useful method for in vitro expansion of the
ESC-like hBSC population for future purposes.
In addition to ESC gene expression and clonogeneicity,
hBSCs demonstrated spontaneous differentiation toward vari-
ous cell types in vitro and were capable of directed differentia-
tion into cell types of mammary, neuroectodermal, mesodermal,
and endodermal origins. The resultant differentiation progressed
to cells that synthesized proteins such as a-lactalbumin/lactofer-
rin/b-casein, albumin, and insulin, which are specific to lacto-
cytes, hepatocytes, and islet cells, respectively.
However, breastmilk cells injected subcutaneously in
immunodeficient mice did not form tumors. Subpopulations of
hESCs and hiPSCs form teratoma-like masses when injected
subcutaneously in immunodeficient SCID mice, an assay that is
used as an indicator of in vivo pluripotency [36, 41]. Neverthe-
less, pluripotent epiblast stem cell subpopulations and adult
cells with pluripotent features (very small embryonic-like cells
(VSELs) and multilineage-differentiating stress-enduring cells
(MUSE cells)) have been previously described failing to form
teratomas when injected subcutaneously in SCID mice [7, 42,
43]. These reports demonstrate that not all pluripotent cells
form teratomas under these conditions [7]. Despite that, these
nontumorigenic pluripotent cells integrate into damaged tissues
when transplanted into immunodeficient mice by local or i.v.
injection [7, 43]. Future work is needed to determine whether
the multilineage-differentiating hBSC populations described
here will similarly integrate into damaged tissues.
In the normal lactating breast, epigenetic modifications of
the ESC-like cells identified here may be responsible for
maintaining a controlled state of self-renewal, preventing
uncontrolled proliferation and tumor formation. Similar theo-
ries have been previously suggested for other adult cells with
pluripotent features (VSELs and MUSE cells) [7, 43]. We
propose that the self-renewal TF network upregulated in the
normal breast during pregnancy/lactation plays a fundamental
Figure 5. Proposed multilineage potential of breastmilk stem cells. Upregulation of the transcription factors (TFs) OCT4, SOX2, and NANOG
during pregnancy and lactation results in broader differentiation potential of a mammary stem cell population under specific microenvironmental
cues. Accessed via breastmilk, these cells can differentiate in corresponding microenvironments into not only the two main mammary epithelial
lineages (green) but also into mesodermal lineages (blue), endodermal lineages (beige), and the neuroectodermal lineage (purple).
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role in the remodeling of the breast necessary to support its
development toward a mature milk-secretory organ. We
hypothesize that the underlying inherent expression of this
pluripotency TF network might provide a priming epigenetic
landscape to these cells to perform multilineage differentiation
in vitro in tissue-specific microenvironments (Fig. 5). Impor-
tantly, disruption of this transcriptional network during preg-
nancy and lactation, failure to silence these genes during
involution, or their aberrant imbalanced upregulation in the
resting breast may be at the core of malignant transformation
in the breast. In accordance with this, we have shown that
forced ectopic expression of OCT4 in cells from the resting
epithelium results in aberrant expansion of MaSCs possessing
multilineage potential and displaying tumor-initiating features
[33], which was in agreement with Tai et al. [27]. Future
work will utilize hBSCs as a model to study molecular deter-
minants of breast cancer associated with deregulation of their
self-renewal machinery.
The multilineage differentiation potential of hBSCs and
the lack of tumor formation in recipient animals suggest the
potential use of hBSCs as a therapeutic alternative to hESCs
and hiPSCs, the use of which is hindered by ethical and safety
issues [36, 44, 45]. Because of its ethical, noninvasive and
plentiful nature, breastmilk offers a novel resource of patient-
specific stem cells for applications in regenerative medicine.
Future work will examine the potential of tissue-specific trans-
plantation and regeneration of damaged/diseased organs using
hBSCs. In particular, the capacity of hBSCs to differentiate
into insulin-producing cells may hold great promise for the
development of personalized treatments for diabetes.
The natural presence in breastmilk of stem cells with mul-
tilineage differentiation potential also raises the question of
the role of these cells during early infant development. Stem
cell exchange between the mother and the embryo occurs in
utero, resulting in microchimerism [46]. This may continue
postnatally via breastfeeding. Indeed, this has been previously
demonstrated for breastmilk leukocytes, which can cross the
digestive epithelium and enter the infant’s systemic circula-
tion [47, 48]. It is proposed that similar to breastmilk leuko-
cytes, hBSCs may also enter the systemic circulation and con-
tribute to tissue homeostasis, repair, and/or regeneration in the
infant. Future research should elucidate the role of these cells
for the breastfed infant, generating implications for public
policy related to early infant nutrition.
CONCLUSIONS
A novel stem cell population was identified in the human lac-
tating mammary gland and accessed noninvasively via breast-
milk. We show that this cell population expresses ESC TFs
ex vivo, expands via upregulation of these genes in 3D sphe-
roid culture, and is capable of differentiating toward cells not
only of the mammary lineage, but also of mesodermal and
endodermal lineages. In the microenvironment of the breast,
upregulation of self-renewal ESC TFs is likely to play a fun-
damental role in the remodeling of the mammary gland dur-
ing pregnancy and lactation toward a milk-secretory organ.
Importantly, deregulation of this self-renewal TF network
might be at the core of invasive breast malignancies. Future
work will establish the usefulness of breastmilk cells as mod-
els in breast cancer research and in regenerative medicine.
Finally, the potential role of these cells for the breastfed
infant merits further investigation.
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